甲状腺功能遗传决定因素与心房颤动的孟德尔随机化研究
研究发现,基因预测的FT3:FT4比值升高和甲状腺功能亢进与房颤风险增加相关,而促甲状腺激素升高和甲状腺功能减退与房颤风险降低相关,但正常范围内的FT4与房颤无关。
要点
- 基因预测的FT3:FT4比值升高与房颤风险增加相关(OR 1.33)。
- 基因预测的甲状腺功能亢进与房颤风险增加相关(MR-Egger OR 1.31)。
- 正常范围内促甲状腺激素升高和甲状腺功能减退与房颤风险降低相关。
核心结论
- 基因预测的FT3:FT4比值升高和甲状腺功能亢进与房颤风险增加相关,而促甲状腺激素升高和甲状腺功能减退与房颤风险降低相关,支持垂体-甲状腺-心脏轴通路。
主要发现
- 汇总级逆方差加权随机效应孟德尔随机化中,基因预测的正常范围内FT4与房颤无关(OR 1.01; 95% CI 0.89-1.14; P=0.88)。
临床怎么用
- 临床评估房颤风险时,除甲状腺功能异常外,可关注FT3:FT4比值及促甲状腺激素水平。
- 对于甲状腺功能亢进患者,应警惕房颤风险增加。
- 甲状腺功能减退或促甲状腺激素偏高可能与房颤风险降低相关,但需结合个体情况。
局限性
- 研究限于欧洲血统人群,结论外推需谨慎。
- 甲状腺功能亢进的孟德尔随机化分析存在水平多效性证据。
- 部分分析异质性较高(如FT4与 incident AF 的 I2=76%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased risk of atrial fibrillation (AF) in observational studies, but direct involvement is unclear. OBJECTIVE: To evaluate the potential direct involvement of thyroid traits on AF. DESIGN, SETTING, AND PARTICIPANTS: Study-level mendelian randomization (MR) included 11 studies, and summary-level MR included 55 114 AF cases and 482 295 referents, all of European ancestry. EXPOSURES: Genomewide significant variants were used as instruments for standardized FT4 and thyrotropin levels within the reference range, standardized triiodothyronine (FT3):FT4 ratio, hypothyroidism, standardized thyroid peroxidase antibody levels, and hyperthyroidism. Mendelian randomization used genetic risk scores in study-level analysis or individual single-nucleotide polymorphisms in 2-sample MR for the summary-level data. MAIN OUTCOMES AND MEASURES: Prevalent and incident AF. RESULTS: The study-level analysis included 7679 individuals with AF and 49 233 referents (mean age [standard error], 62 [3] years; 15 859 men [29.7%]). In study-level random-effects meta-analysis, the pooled hazard ratio of FT4 levels (nanograms per deciliter) for incident AF was 1.55 (95% CI, 1.09-2.20; P = .02; I2 = 76%) and the pooled odds ratio (OR) for prevalent AF was 2.80 (95% CI, 1.41-5.54; P = .003; I2 = 64%) in multivariable-adjusted analyses. The FT4 genetic risk score was associated with an increase in FT4 by 0.082 SD (standard error, 0.007; P < .001) but not with incident AF (risk ratio, 0.84; 95% CI, 0.62-1.14; P = .27) or prevalent AF (OR, 1.32; 95% CI, 0.64-2.73; P = .46). Similarly, in summary-level inverse-variance weighted random-effects MR, gene-based FT4 within the reference range was not associated with AF (OR, 1.01; 95% CI, 0.89-1.14; P = .88). However, gene-based increased FT3:FT4 ratio, increased thyrotropin within the reference range, and hypothyroidism were associated with AF with inverse-variance weighted random-effects OR of 1.33 (95% CI, 1.08-1.63; P = .006), 0.88 (95% CI, 0.84-0.92; P < .001), and 0.94 (95% CI, 0.90-0.99; P = .009), respectively, and robust to tests of horizontal pleiotropy. However, the subset of hypothyroidism single-nucleotide polymorphisms involved in autoimmunity and thyroid peroxidase antibodies levels were not associated with AF. Gene-based hyperthyroidism was associated with AF with MR-Egger OR of 1.31 (95% CI, 1.05-1.63; P = .02) with evidence of horizontal pleiotropy (P = .045). CONCLUSIONS AND RELEVANCE: Genetically increased FT3:FT4 ratio and hyperthyroidism, but not FT4 within the reference range, were associated with increased AF, and increased thyrotropin within the reference range and hypothyroidism were associated with decreased AF, supporting a pathway involving the pituitary-thyroid-cardiac axis.
引用
- Ellervik C, Roselli C, Christophersen IE, et al. Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study. JAMA Cardiol. 2019. PMID: 30673084. doi:10.1001/jamacardio.2018.4635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。